A new study suggests that drugs like Ozempic and Mounjaro may reduce dementia risk. Researchers at the University of Galway found a 45% lower risk in patients taking these medications. The drugs may ...

Because chronic inflammation is key to aging, Ozempic’s anti-inflammatory effects (among others) make it a powerful anti-aging drug, according to a new study. The non-peer-reviewed study shows that ...

As the list of health benefits of semaglutide drugs grows, perhaps it is time to think about assessing their impact on people ...

Ozempic use is associated with a lowered risk for cognitive problems, researchers in a new study said. The findings, however, cannot be applied to users who do not have diabetes. The study, publish… ...

FAT jabs are better than widely prescribed metformin when it comes to curbing dementia risk in people with type 2 diabetes, say scientists. While both medications demonstrate neuroprotective ...

Benefits were most prominent among women, patients older than 60 and those with a body mass index of 30 to 40.

Of the 26 trials reviewed, 23 reported cases of cognitive impairment or dementia after a six-month follow-up. Participants who took GLP-1 agonists like Ozempic were less likely to show signs of ...

News Ozempic ingredient linked to reduced dementia risk in diabetes patients, CWRU study shows Published: Jul. 15, 2025, 10:23 a.m.

Semaglutide — the active ingredient in type 2 diabetes and weight-loss glucagon-like peptide-1 agonist ( GLP-1) medications Ozempic and Wegovy — may help lower dementia risk, a new study finds.

GLP-1 drugs often cause weight loss because they mimic the GLP-1 hormone the body naturally produces after eating. Appetite ...

Business Ozempic linked to lower dementia rate in Oxford study After a year on the drug, patients had a 48% lower risk of dementia compared with those who’d taken sitagliptin.

Ozempic use is associated with a lowered risk for cognitive problems, researchers in a new study said. The findings, however, cannot be applied to users who do not have diabetes. The study ...